Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bagot

Showing results (391-400 of 412) with videos related to

Pageof 42
Sort By:
The American Journal of Surgical Pathology|October 20, 1998
Statistical evaluation of diagnostic and prognostic features of CD30+ cutaneous lymphoproliferative disorders: a clinicopathologic study of 65 casesB Vergier, M Beylot-Barry, K Pulford, et al.
The British Journal of Dermatology|February 3, 2016
Phase II multicentre trial of oral quisinostat, a histone deacetylase inhibitor, in patients with previously treated stage IB-IVA mycosis fungoides/Sézary syndromeF Child, P L Ortiz-Romero, R Alvarez, et al.
Clinical and Experimental Dermatology|May 14, 2021
Lymphomatoid papulosis types D and E: a multicentre series of the French Cutaneous Lymphomas Study GroupC Bergqvist, M Beylot-Barry, C Ram-Wolff, et al.
Annales De Dermatologie Et De Venereologie|April 18, 2018
Cutaneous presentation of adult T-cell leukemia/lymphoma (ATLL). Single-center study on 37 patients in metropolitan France between 1996 and 2016C Hurabielle, M Battistella, C Ram-Wolff, et al.
The British Journal of Dermatology|January 11, 2014
Skin ulcers related to chronic graft-versus-host disease: clinical findings and associated morbidityM Jachiet, A de Masson, R Peffault de Latour, et al.
Blood|March 25, 2000
Transformation of mycosis fungoides: clinicopathological and prognostic features of 45 cases. French Study Group of Cutaneious LymphomasB Vergier, A de Muret, M Beylot-Barry, et al.
The British Journal of Dermatology|January 10, 2018
KIR3DL2 expression in patients with adult T-cell lymphoma/leukaemiaC Hurabielle, C Leboeuf, C Ram-Wolff, et al.
The British Journal of Dermatology|July 8, 2015
Frequency and prognostic value of cutaneous molecular residual disease in mycosis fungoides: a prospective multicentre trial of the Cutaneous Lymphoma French Study GroupC Hurabielle, S Ingen-Housz-Oro, N Ortonne, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 8, 2024
Consensus statement on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: Localized scleroderma, systemic sclerosis and overlap syndromesR Knobler, M Geroldinger-Simić, A Kreuter, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 7, 2020
European dermatology forum - updated guidelines on the use of extracorporeal photopheresis 2020 - part 1R Knobler, P Arenberger, A Arun, et al.
Pageof 42

Showing results (391-400 of 412) with videos related to

Sort By:
Pageof 42
The American Journal of Surgical Pathology|October 20, 1998
Statistical evaluation of diagnostic and prognostic features of CD30+ cutaneous lymphoproliferative disorders: a clinicopathologic study of 65 casesB Vergier, M Beylot-Barry, K Pulford, et al.
The British Journal of Dermatology|February 3, 2016
Phase II multicentre trial of oral quisinostat, a histone deacetylase inhibitor, in patients with previously treated stage IB-IVA mycosis fungoides/Sézary syndromeF Child, P L Ortiz-Romero, R Alvarez, et al.
Clinical and Experimental Dermatology|May 14, 2021
Lymphomatoid papulosis types D and E: a multicentre series of the French Cutaneous Lymphomas Study GroupC Bergqvist, M Beylot-Barry, C Ram-Wolff, et al.
Annales De Dermatologie Et De Venereologie|April 18, 2018
Cutaneous presentation of adult T-cell leukemia/lymphoma (ATLL). Single-center study on 37 patients in metropolitan France between 1996 and 2016C Hurabielle, M Battistella, C Ram-Wolff, et al.
The British Journal of Dermatology|January 11, 2014
Skin ulcers related to chronic graft-versus-host disease: clinical findings and associated morbidityM Jachiet, A de Masson, R Peffault de Latour, et al.
Blood|March 25, 2000
Transformation of mycosis fungoides: clinicopathological and prognostic features of 45 cases. French Study Group of Cutaneious LymphomasB Vergier, A de Muret, M Beylot-Barry, et al.
The British Journal of Dermatology|January 10, 2018
KIR3DL2 expression in patients with adult T-cell lymphoma/leukaemiaC Hurabielle, C Leboeuf, C Ram-Wolff, et al.
The British Journal of Dermatology|July 8, 2015
Frequency and prognostic value of cutaneous molecular residual disease in mycosis fungoides: a prospective multicentre trial of the Cutaneous Lymphoma French Study GroupC Hurabielle, S Ingen-Housz-Oro, N Ortonne, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 8, 2024
Consensus statement on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: Localized scleroderma, systemic sclerosis and overlap syndromesR Knobler, M Geroldinger-Simić, A Kreuter, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 7, 2020
European dermatology forum - updated guidelines on the use of extracorporeal photopheresis 2020 - part 1R Knobler, P Arenberger, A Arun, et al.
Pageof 42